Economy

Add as a preferred source on Google

US Stock Futures Dip Ahead of Powell Speech, PPI Data

U.S. stock index futures edged lower Wednesday evening as investors awaited key inflation data and monetary policy signals from Federal Reserve Chair Jerome Powell. The dip followed a mixed day on Wall Street, where tech…

Updated 2 min read
US Stock Futures Dip Ahead of Powell Speech, PPI Data. Source: B64 at English Wikipedia, CC BY 3.0, via Wikimedia Commons
US Stock Futures Dip Ahead of Powell Speech, PPI Data. Source: B64 at English Wikipedia, CC BY 3.0, via Wikimedia Commons

Read the original article

U.S. stock index futures edged lower Wednesday evening as investors awaited key inflation data and monetary policy signals from Federal Reserve Chair Jerome Powell. The dip followed a mixed day on Wall Street, where tech stocks outperformed amid ongoing optimism around artificial intelligence, while broader sectors showed weakness.

S&P 500 futures slipped 0.1% to 5,896.25, Nasdaq 100 futures dropped 0.1% to 21,372.25, and Dow Jones futures led declines, down 0.5% to 41,929.0 as of 8:00 p.m. ET.

Markets are now focused on Thursday’s U.S. producer price index (PPI) release, expected to show moderating factory-level inflation for April. The report comes on the heels of softer-than-expected consumer price index (CPI) data, which sparked hopes of potential interest rate cuts if inflation continues to cool.

All eyes are also on Jerome Powell’s speech Thursday, where he will review the Fed’s policy framework. Investors are looking for hints on future rate decisions, especially after the Fed recently held rates steady and signaled caution due to economic uncertainty.

On Wednesday, Wall Street indexes saw varied performance. The Nasdaq climbed 0.7% to 19,146.81, lifted by gains in AI-linked tech stocks like SuperMicro, which surged over 15%, and CoreWeave, up 6.6% during the session before tumbling nearly 8% after hours on margin concerns. The S&P 500 rose 0.1% to 5,892.58, while the Dow fell 0.2% to 42,051.06.

In after-hours trading, UnitedHealth Group (NYSE:UNH) dropped more than 7% following a Wall Street Journal report that the company is under DOJ investigation for alleged Medicare fraud. The stock is now down nearly 39% year-to-date, amid rising regulatory pressure and leadership changes.

Related articles

View all